Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
738
datasets available to search
ShareScore release 0.7.1
Dataset results
738 results for “Adverse events”
The Incidence and Risk Factors of Central Nervous System Adverse Events of Lorlatinib in Patients with ALK-positive Advanced Non-small Cell Lung Cancer: a Real-world Study
ClinicalTrials.gov study NCT06652555. IPD Sharing: YES. Countries: 0. Publications: 0.
Radial Artery Patency and Bleeding, Efficacy, Adverse evenT Trial
ClinicalTrials.gov study NCT02269449. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Impact of Preoperative VFA on Intraoperative Adverse Events in Patients Undergoing Laparoscopic Radical Gastrectomy
ClinicalTrials.gov study NCT06506331. IPD Sharing: NO. Countries: 0. Publications: 0.
Patient-reported Adverse Events From Osteopathic Manipulative Treatment
ClinicalTrials.gov study NCT02386085. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Efficacy of Different Perioperative Statin Regimens on the Protection Against Post Coronary Artery Bypass Grafting Major Adverse Cardio-cerebral Events
ClinicalTrials.gov study NCT02706860. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT05660421. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Risk of Serious Adverse Events Following Unsupervised vs Supervised Rehabilitation After Knee Arthroplasty
ClinicalTrials.gov study NCT07067060. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Effect of Anticoagulant and Antiplatelet Drug Intervention on Postoperative Major Adverse Events in Patients with PAD：Phase II
ClinicalTrials.gov study NCT06850207. IPD Sharing: NO. Countries: 0. Publications: 0.
Use of Integrated Pulmonary Index to Predict Post-Operative Respiratory Adverse Events in High Risk Patients
ClinicalTrials.gov study NCT03275324. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Establish a Telecare Model of Acute Coronary Syndrome Patient With Heart Stent Implantation by a Non-invasive Wearable Device and Artificial Intelligence Cloud to Reducing Medical Adverse Events.
ClinicalTrials.gov study NCT04455568. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
ClinicalTrials.gov study NCT06396858. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis
ClinicalTrials.gov study NCT02264964. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)
ClinicalTrials.gov study NCT01685424. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor Efficacy [RNA-seq (human)]
GEO Series GSE192580. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Adverse Events of anti-EGFR Therapy are Triggered by Hair Eruption and Commensal Skin Microbiota
GEO Series GSE119376. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
Association of miR-197-5p, a circulating biomarker for heart failure, with myocardial fibrosis and adverse cardiovascular events among patients with stage C or D heart failure
GEO Series GSE104150. Homo sapiens. 16 samples. Type: Non-coding RNA profiling by array.
dataset related to article "Adverse Events in Neurosurgery: The Novel Therapy-Disability-Neurology Grade"
<p>Dataset related to publication at title</p>
ENDOTHELIN-1 AS PREDICTOR OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN CHRONIC CORONARY SYNDROME PATIENTS UNDERGOING CORONARY INTERVENTION
<p><strong>Background</strong>: Major Adverse Cardiovascular Events (MACE) are believed to have very low in Chronic Coronary Syndrome (CCS) patients who have undergone percutaneous coronary intervention (PCI). Endothelin-1 had been considered as pro inflammatory biomarker and suggested as a novel prognostic indicator in CCS.</p> <p><strong>Objective</strong>: To prove Endothelin- 1 as predictor of MACE within 1-year evaluation in CCS patients undergoing PCI.</p> <p><strong>Methods</strong>: Analytic observational study with cohort design. The sample were CCS patients whom performed PCI. Endotelin-1 levels were checked before patient undergone PCI. Occurrences of MACE observed within 1 year. The comparison between normally distributed continuous data was performed with <em>T</em>-test, <em>Mann–Whitney</em> test was used for not normally distributed. Comparison between categorical data was performed with the Chi-square test<em>.</em> Cut-off point of Endothelin-1 levels to predict MACE analyzed by Receiver Operating Characteristics (ROC).</p> <p><strong>Results: </strong>Subject of this study were 63 patients. Six patients experienced MACE within 1 year (9.5%) and 57 patients were included in No MACE group (90.5%). <em>Mann Whitney T test</em> showed there were significance differences in Endothelin-1 levels from the two groups (p=0.022). The ROC curve showed cut off point the Endothelin-1 is 4.07 ng/dl with a sensitivity of 83.3%, specificity of 75.4% and accuracy of 76.2%. Based on the AUC value and the accuracy of this study, Endothelin-1 was able to detect MACE within 1 year of follow-up.</p> <p><strong>Conclusions: </strong>Endothelin-1 can be used as predictor of MACE within 1year evaluation in CCS patients undergoing coronary intervention.</p> <p><strong>Background</strong>: Major Adverse Cardiovascular Events (MACE) are believed to have very low in Chronic Coronary Syndrome (CCS) patients who have undergone percutaneous coronary intervention (PCI). Endothelin-1 had been considered as pro inflammatory biomarker and suggested as a novel prognostic indicator in CCS.</p> <p><strong>Objective</strong>: To prove Endothelin- 1 as predictor of MACE within 1-year evaluation in CCS patients undergoing PCI.</p> <p><strong>Methods</strong>: Analytic observational study with cohort design. The sample were CCS patients whom performed PCI. Endotelin-1 levels were checked before patient undergone PCI. Occurrences of MACE observed within 1 year. The comparison between normally distributed continuous data was performed with <em>T</em>-test, <em>Mann–Whitney</em> test was used for not normally distributed. Comparison between categorical data was performed with the Chi-square test<em>.</em> Cut-off point of Endothelin-1 levels to predict MACE analyzed by Receiver Operating Characteristics (ROC).</p> <p><strong>Results: </strong>Subject of this study were 63 patients. Six patients experienced MACE within 1 year (9.5%) and 57 patients were included in No MACE group (90.5%). <em>Mann Whitney T test</em> showed there were significance differences in Endothelin-1 levels from the two groups (p=0.022). The ROC curve showed cut off point the Endothelin-1 is 4.07 ng/dl with a sensitivity of 83.3%, specificity of 75.4% and accuracy of 76.2%. Based on the AUC value and the accuracy of this study, Endothelin-1 was able to detect MACE within 1 year of follow-up.</p> <p><strong>Conclusions: </strong>Endothelin-1 can be used as predictor of MACE within 1year evaluation in CCS patients undergoing coronary intervention.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.